FINWIRES · TerminalLIVE
FINWIRES

Huadong Medicine's Weight-Loss Drug Marketing Application Accepted in China

-- Huadong Medicine (SHE:000963) said China's drug administrator accepted its marketing application for semaglutide injection.

The drug is used for long-term weight management in obese or overweight adults, according to a Wednesday filing with the Shenzhen bourse.

Shares of the drugmaker closed 2% higher Wednesday.

相關文章